Leaderboard

En | De
Sie sind hier: Onkologie » Urologische Tumoren 17. Juli 2025
Suchen
medline.ch
Urologische Tumoren
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Bewegungsapparat
Blut
Endokrine Organe
Gynäkologische Tumoren
Haut
Magen-Darm
ORL
Respirationstrakt
Urologische Tumoren
ZNS
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Sportmedizin
Urologie-Nephrologie
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 8443  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 168847  
   
Unplanned hospitalization among advanced prostate cancer patients by diabetes status-a population-based study.
JNCI Cancer Spectr
Shaver AL, Gandhi K, Keith SW, Nikita N, Yang CC, Kim FJ, Yang H, Kelly WK, Freedland SJ, Lu-Yao G.
PMID: 40668753 [PubMed - as supplied by publisher]


Reinforcing expectations after robot-assisted intracorporeal orthotopic neobladder: long-term functional, urodynamic and metabolic outcome.
World J Urol
Kraft P, Schregel C, Obrecht F, Foerster B, Froelicher G, Burkhardt O, Boehler K, Padevit C, Tornic J, Wiklund P, John H.
PMID: 40668322 [PubMed - indexed for MEDLINE]


Rectus diastasis is a risk factor for incisional hernia after robot assisted laparoscopic radical prostatectomy for prostate cancer.
Hernia
Honma S, Ishikawa K, Kumode T, Suzuki T, Murakami T, Hosokawa S, Kan T, Nakajima S.
PMID: 40668292 [PubMed - indexed for MEDLINE]


[Neuroendocrine differentiation in prostate neoplasms. German version].
Pathologie (Heidelb)
Grobholz R.
PMID: 40668272 [PubMed - as supplied by publisher]


The institutional impact of robotic surgery adoption: evidence from prostate and thyroid cancers in South Korea.
J Robot Surg
Ro J, Do YK.
PMID: 40668261 [PubMed - indexed for MEDLINE]


A systematic review of the latest progress of drug resistance and clinical application of immunotherapy in renal cell carcinoma in the past five years based on bibliometrics.
Hum Vaccin Immunother
Wu Y, Liang J, Liang Y, Ma Y.
PMID: 40667694 [PubMed - indexed for MEDLINE]


A hematological and inflammatory marker-based model for prostate carcinoma diagnosis.
Am J Cancer Res
Guo P, A G, Chen T, Guo Y, Tang Y, Pan J, Wang B, Gong R, Chen G, Huang S.
PMID: 40667539 [PubMed]


Subinguinal Orchidectomy for Testicular Cancer: Innovation or Unnecessary Advancement.
Cureus
Jacob D, Chitteti P, Mubarak M, Nadeem M.
PMID: 40666550 [PubMed]


Cost effectiveness analysis of prostate cancer screening strategies in Germany: A microsimulation study.
Int J Cancer
Muchadeyi MT, Hao S, Hernandez-Villafuerte K, Khan SA, Becker N, Krilaviciute A, Seibold P, Gulati R, Albers P, Schlander M, Clements M.
PMID: 40665795 [PubMed - as supplied by publisher]


Penile Cancer Distant Metastasis or Primary Lung Cancer? Using Focused Genomic Profiling of Tumor and Germline Mutations With Next-Generation Sequencing for Clinical Decision-Making.
Cancer Rep (Hoboken)
Moen CA, Nordanger IM, Karlsdóttir Á, Honoré A, Juliebø-Jones P, Blomberg SM, Haslerud TM, Aamelfot C, Salminen PR, Beisland C, Vetti HH, Costea DE, Berget E.
PMID: 40665654 [PubMed - indexed for MEDLINE]


Response to Veldi et al.: 'The diagnostic value of MRI for persistent prostate cancer following irreversible electroporation focal therapy' - a critical appraisal.
BJU Int
Zhang K, Teoh J, Laguna P, de la Rosette J.
PMID: 40665600 [PubMed - as supplied by publisher]


The tumour sink effect on (68)Ga-PSMA-PET/CT in metastatic castration-resistant prostate cancer and its implications for PSMA-RPT: a sub-analysis of the 3TMPO study.
Cancer Imaging
Zamanian A, Rousseau É, Buteau FA, Arsenault F, Beaulieu A, April G, Juneau D, Plouznikoff N, Turcotte ÉE, Allard C, Richard PO, Saad F, Guérin B, Pouliot F, Beauregard JM.
PMID: 40665456 [PubMed - indexed for MEDLINE]


Posterior conduit fixation with retroperitonealization of uretero-ileal anastomosis after open radical cystectomy reduces the postoperative complication rate: a retrospective, matched-paired single-center analysis.
BMC Urol
Marko V, Petar K, Aleksandar M, Marko A, Almir R, Eldin S.
PMID: 40665273 [PubMed - indexed for MEDLINE]


Re: Piet Ost, Shankar Siva, Sigmund Brabrabd, et al. Salvage Metastasis-directed Therapy Versus Elective Nodal Radiotherapy for Oligorecurrent Nodal Prostate Cancer Metastases (PEACE V-STORM): A Phase 2, Open-label, Randomised Controlled Trial. Lancet Oncol 2025;26:695-706.
Eur Urol Focus
Vis AN, van den Bergh RCN.
PMID: 40664550 [PubMed - as supplied by publisher]


Genetic Insights Into Nephrolithiasis and Renal Cancer Predisposition: Precision Medicine in Genes, Diagnosis, and Therapy.
Semin Nephrol
Wu CW, Huang YM, Ziadeh H, Jong BE, Dalal P, Lin HC, Majmundar A, Tsai YC, Hijaz A, Stoller ML, Romero M, Hildebrandt F.
PMID: 40664523 [PubMed - as supplied by publisher]


Radical Surgery Compared to Bladder-Preserving Approaches for Limited Stage Small-Cell Bladder Cancer: Systematic Review and Meta-Analysis.
Clin Genitourin Cancer
Kubik A, das Virgens IPA, Varga N, Szabó A, Keszthelyi A, Fehérvári P, Hegyi P, Ács N, Nyirády P, Szarvas T.
PMID: 40664516 [PubMed - as supplied by publisher]


Driven early detection of chronic kidney cancer disease based on machine learning technique.
PLoS One
Almukadi W, Abdel-Khalek S, Bahaddad AA, Alghamdi AM.
PMID: 40663560 [PubMed - indexed for MEDLINE]


Survival benefits of Cytoreductive Nephrectomy in patients with metastatic renal cell carcinoma: evidence from a SEER-based retrospective cohort study.
PLoS One
Peng X, Duan L, Wu Q, Wu S, Wang W, Shi R.
PMID: 40663535 [PubMed - indexed for MEDLINE]


Molecular characterization of residual muscle-invasive bladder cancer identifies a scar-like transcriptomicprofile with favorable prognosis after neoadjuvant therapy.
Clin Cancer Res
de Jong JJ, Reike MJ, Lotan Y, Seiler R, Davicioni E, Necchi A, Powles T, Black PC, Szabados B, Gibb EA.
PMID: 40663496 [PubMed - as supplied by publisher]


A machine learning-based screening model for the early detection of prostate cancer developed using serum microRNA data from a mixed cohort of 8,741 participants.
Discov Oncol
Lai C, Hu Z, Li Z, Wu Z, Li K, Li L, Liu H, Shi J, Zhou Y, Xu K, Liu C.
PMID: 40663312 [PubMed]


   
   Artikel 1 - 20 / 168847    Seite 1 von 8443  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

 

Übersetzungsproblem?

mehr >>

  Zeitfenster  
   

Sky right 1